Clinical Trial Update: Breast Cancer Margin Delineation Using Polarization Subtraction Imaging Technology [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 clinical trial update discusses using polarization subtraction imaging to delineate breast cancer margins.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: LumaMed | Conditions: Breast Cancer | EARLY_Phase 1 | Status: UNKNOWN